
Results of the PULSE-MI trial show that in pts with STEMI, prehospital pulse-dose glucocorticoid did not reduce final infarct size after 3 mos. Patients treated with glucocorticoid had higher acute LVEF, reduced acute infarct size, & less MVO. ja.ma/4g4H5zi #ESCCongress












